PF-06928215

PF-06928215 Struktur
2378173-15-8
CAS-Nr.
2378173-15-8
Englisch Name:
PF-06928215
Synonyma:
PF-06928215;Inhibitor,PF-06928215,cGAS,inhibit,PF 06928215,Cyclic GMP-AMP Synthase,PF06928215;Cyclohexanecarboxylic acid, 2-[[(7-hydroxy-5-phenylpyrazolo[1,5-a]pyrimidin-3-yl)carbonyl]amino]-, (1R,2S)-
CBNumber:
CB28096285
Summenformel:
C20H20N4O4
Molgewicht:
380.4
MOL-Datei:
2378173-15-8.mol

PF-06928215 Eigenschaften

storage temp. 
Store at -20°C
Löslichkeit
DMSO: 30 mg/ml
Aggregatzustand
A solid
Farbe
White to off-white

Sicherheit

PF-06928215 Chemische Eigenschaften,Einsatz,Produktion Methoden

PF-06928215 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


PF-06928215 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 24)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Wuhan Topule Biopharmaceutical Co., Ltd
+8618327326525
masar@topule.com China 8474 58
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 57511 58
ShangHai Caerulum Pharma Discovery Co., Ltd. 18149758185
sales-cpd@caerulumpharma.com China 3453 58
Shanghai Chaolan Chemical Technology Center QQ:65489617 15618227136
info@SuperLan-chem.com China 9874 58
Beijing Solarbio Science & Tecnology Co., Ltd. 010-50973130 4009686088
3193328036@qq.com China 29795 68
Dezhou LonWel Pharmaceutical Technology Co., Ltd. 13761310616
39324283@qq.com China 1985 58
Jiangsu yize medical technology co. LTD 18550739526
23903480@qq.com China 5841 58
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767
sales@chemegen.com China 11289 58
Jiangsu yize medical technology co. LTD 18962082606
3394205705@qq.com China 8820 58

  • Cyclohexanecarboxylic acid, 2-[[(7-hydroxy-5-phenylpyrazolo[1,5-a]pyrimidin-3-yl)carbonyl]amino]-, (1R,2S)-
  • PF-06928215
  • Inhibitor,PF-06928215,cGAS,inhibit,PF 06928215,Cyclic GMP-AMP Synthase,PF06928215
  • 2378173-15-8
Copyright 2019 © ChemicalBook. All rights reserved